Filter news stories by category:
- UCLH news
- Charity news
-
Research news
- Governors news
- Red Cell Network news
- HTD news
- Reset filter
-
Research news
25 November 2020
A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
-
Research news
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.
-
Research news
27 October 2020
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
Research news
07 October 2020
Sir Simon Stevens, CEO of NHS England visited our long COVID-19 clinic today to learn more about the service at UCLH.
-
Research news
07 October 2020
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
Research news
01 October 2020
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Research news
16 September 2020
A study supported by the NIHR UCLH Biomedical Research Centre carried out at UCL has found that people who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life.
-
Research news
28 August 2020
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
Research news
28 August 2020
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
-
Research news
20 August 2020
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.